Autor: "Wolfgang Blau" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Standardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma
Autorzy :: Agnieszka Blum
Katy Haussmann
Mathias Streitz
Stephan Schlickeiser
Carola Tietze-Buerger
Igor Wolfgang Blau
Lutz Uharek; Pokaż więcej
Temat :: Medicine
Science
Źródło :: Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Opis pliku :: electronic resource
Relacje :: http://link.springer.com/article/10.1038/s41598-019-39631-2; https://doaj.org/toc/2045-2322
Dostęp URL :: https://doaj.org/article/596a2799e5f341698ef7ef2e39a4b5ef
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 2 2.

Tytuł :: The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI
Autorzy :: Salah-Eddin Al-Batran
Thorsten O. Goetze
Daniel W. Mueller
Arndt Vogel
Michael Winkler
Sylvie Lorenzen
Alexander Novotny
Claudia Pauligk
Nils Homann
Thomas Jungbluth
Christoph Reissfelder
Karel Caca
Steffen Retter
Eva Horndasch
Julia Gumpp
Claus Bolling
Karl-Hermann Fuchs
Wolfgang Blau
Winfried Padberg
Michael Pohl
Andreas Wunsch
Patrick Michl
Frank Mannes
Matthias Schwarzbach
Harald Schmalenberg
Michael Hohaus
Christian Scholz
Christoph Benckert
Jorge Riera Knorrenschild
Veit Kanngießer
Thomas Zander
Hakan Alakus
Ralf-Dieter Hofheinz
Claus Roedel
Manish A. Shah
Mitsuru Sasako
Dietmar Lorenz
Jakob Izbicki
Wolf O. Bechstein
Hauke Lang
Stefan P. Moenig; Pokaż więcej
Temat :: Oligometastatic cancer
Metastatic gastric cancer
Metastatic gastroesophageal junction cancer
Limited-metastatic disease
Localized peritoneal carcinomatosis
Perioperative chemotherapy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło :: BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Opis pliku :: electronic resource
Relacje :: http://link.springer.com/article/10.1186/s12885-017-3918-9; https://doaj.org/toc/1471-2407
Dostęp URL :: https://doaj.org/article/5dc6e803a3084cd49c26c2fd2d3bd2f4
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: Somatic Mutations in Myelodysplastic Syndrome Patients in the Context of Allogeneic Stem Cell Transplantation
Autorzy :: Olga Blau
Rolf Schwarzer
Igor Wolfgang Blau; Pokaż więcej
Temat :: myelodysplastic syndrome (mds)
somatic mutations
allogeneic stem cell transplantation (allosct)
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło :: European Medical Journal Oncology, Vol 4, Iss 1, Pp 122-129 (2016)
Opis pliku :: electronic resource
Relacje :: https://www.emjreviews.com/oncology/article/somatic-mutations-in-myelodysplastic-syndrome-patients-in-the-context-of-allogeneic-stem-cell-transplantation/; https://doaj.org/toc/2054-619X
Dostęp URL :: https://doaj.org/article/2b172d94618b49f8838c053d9ae2b6f3
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Introductory Editorial: Tyrosine Kinases in Cancer
Autorzy :: Olga Blau
Boris Afanasyev
Igor Wolfgang Blau; Pokaż więcej
Temat :: Medicine (General)
R5-920
Źródło :: Biomarker Insights, Vol 10s3 (2015)
Opis pliku :: electronic resource
Relacje :: https://doaj.org/toc/1177-2719
Dostęp URL :: https://doaj.org/article/3087aad75473442987e512c0c8057bef
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Efficacy and Pharmacologic Data of Second-Generation Tyrosine Kinase Inhibitor Nilotinib in BCR-ABL-Positive Leukemia Patients with Central Nervous System Relapse after Allogeneic Stem Cell Transplantation
Autorzy :: Mark Reinwald
Eberhard Schleyer
Philipp Kiewe
Igor Wolfgang Blau
Thomas Burmeister
Stefan Pursche
Martin Neumann
Michael Notter
Eckhard Thiel
Wolf-Karsten Hofmann
Hans-Jochem Kolb
Stefan Burdach
Hans-Ulrich Bender; Pokaż więcej
Temat :: Medicine
Źródło :: BioMed Research International, Vol 2014 (2014)
Opis pliku :: electronic resource
Relacje :: https://doaj.org/toc/2314-6133; https://doaj.org/toc/2314-6141
Dostęp URL :: https://doaj.org/article/c7979c2a83fb4df0a68f82d8e999a46e
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 6 6.

Tytuł :: Comparative examination of various PCR-based methods for DNMT3A and IDH1/2 mutations identification in acute myeloid leukemia.
Autorzy :: Berenstein, Rimma
Wolfgang Blau, Igor igor.blau@charite.de
Kar, Asiye
Cay, Ruhiye
Sindram, Annette
Seide, Claudia
Blau, Olga olga.blau@charite.de; Pokaż więcej
Źródło :: Journal of Experimental & Clinical Cancer Research (17569966). 2014, Vol. 33 Issue 1, p1-25. 25p.
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 7 7.

Tytuł :: The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
Autorzy :: Al-Batran, Salah-Eddin
Goetze, Thorsten O.
Mueller, Daniel W.
Vogel, Arndt
Winkler, Michael
Lorenzen, Sylvie
Novotny, Alexander
Pauligk, Claudia
Homann, Nils
Jungbluth, Thomas
Reissfelder, Christoph
Caca, Karel
Retter, Steffen
Horndasch, Eva
Gumpp, Julia
Bolling, Claus
Fuchs, Karl-Hermann
Wolfgang Blau
Padberg, Winfried
Pohl, Michael; Pokaż więcej
Temat :: CHEMOTHERAPY (Cancer)
QUALITY of life
SURGICAL excision
ADENOCARCINOMA
CANCER invasiveness
ESOPHAGOGASTRIC junction cancer
STOMACH cancer -- Treatment
SURVIVAL analysis (Biometry)
CANCER treatment
ANTINEOPLASTIC agents
CLINICAL trials
COMBINED modality therapy
COMPARATIVE studies
DIGESTIVE organ surgery
ESOPHAGUS
ESOPHAGEAL tumors
GASTRECTOMY
LONGITUDINAL method
RESEARCH methodology
MEDICAL cooperation
METASTASIS
PROGNOSIS
QUESTIONNAIRES
RESEARCH
RESEARCH funding
STOMACH tumors
SURVIVAL
EVALUATION research
TUMOR treatment
Źródło :: BMC Cancer; 12/28/2017, Vol. 17, p1-7, 7p
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 8 8.

Tytuł :: Lack of Evidence That False-Positive Aspergillus Galactomannan Antigen Test Results Are Due to Treatment with Piperacillin-Tazobactam
Autorzy :: Olaf Penack
Stefan Schwartz
Eckhard Thiel
Igor Wolfgang Blau; Pokaż więcej
Źródło :: Clinical Infectious Diseases. 39(9):1401-1402
Dostęp URL :: https://www.jstor.org/stable/4462949
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Das fehlertolerante DELTA-System
Autorzy :: Wolfgang Blau
Karl May
Claus Schirmer; Pokaż więcej
Źródło :: Architektur und Betrieb von Rechensystemen : 8. GI-NTG-Fachtagung Karlsruhe, 26.–28. März 1984. :247-257
: Książka elektroniczna

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Fault tolerance in distributed UNIX
Autorzy :: Anita Borg
Wolfgang Blau
Wolfgang Oberle
Wolfgang Graetsch; Pokaż więcej
Źródło :: Fault-Tolerant Distributed Computing. :224-243
: Książka elektroniczna

Szczegóły

Skocz do pozycji: 11 11.

Informacja :: Dostęp do tej pozycji wymaga zalogowania się.
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years.
Autorzy :: Bazarbachi A; Bone marrow Transplant Program, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon. .
Schmid C; Department of Haematology and Oncology, Augsburg University Hospital and Medical Faculty, Augsburg, Germany. .
Labopin M; Department of Haematology and EBMT Paris Study Office/CEREST-TC, Saint Antoine Hospital, Paris, France.
Beelen D; Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
Wolfgang Blau I; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Potter V; Department of Haematological Medicine, GKT School of Medicine, London, United Kingdom.
Niittyvuopio R; HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland.
Socié G; Programme de Transplantation & Thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
Blaise D; Programme de Transplantation & Thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
Sanz J; Department of Hematology (Torre F, Planta 7), University Hospital La Fe, Valencia, Spain.
Ciceri F; Ospedale San Raffaele s.r.l., Haematology and BMT, Milano, Italy.
Abou Dalle I; Bone marrow Transplant Program, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Spyridonidis A; Department of Internal Medicine, BMT Unit, University Hospital of Patras, Patras, Greece.
Bug G; Goethe-Universitaet, Medizinische Klinik II, Hämatologie, Medizinische Onkologie, Frankfurt Main, Germany.
Esteve J; Department of Hematology, Hospital Clinic, Institute of Hematology & Oncology, Barcelona, Spain.
Savani BN; Vanderbilt University Medical Center, Nashville, Tennessee.
Nagler A; Department of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel HaShomer, Ramat Gan, Israel.
Mohty M; Department of Clinical Hematology and Cellular Therapy, Saint-Antoine Hospital, INSERM UMR 938 and Sorbonne University, Paris, France.; Pokaż więcej
Źródło :: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Dec 15; Vol. 26 (24), pp. 6475-6482. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Single Nucleotide Polymorphisms in CD40L Predict Endothelial Complications and Mortality After Allogeneic Stem-Cell Transplantation.
Autorzy :: Rachakonda SP; Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.
Dai H; Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.
Penack O; Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.
Blau O; Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.
Blau IW; Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.
Radujkovic A; Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.
Müller-Tidow C; Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.
Kumar R; Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.
Dreger P; Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.
Luft T; Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.; Pokaż więcej
Źródło :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Mar 10; Vol. 36 (8), pp. 789-800. Date of Electronic Publication: 2018 Jan 25.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: CD40 Ligand/*metabolism
Endothelial Cells/*metabolism
Hematopoietic Stem Cell Transplantation/*adverse effects
Polymorphism, Single Nucleotide/*genetics
Transplantation Conditioning/*adverse effects
Transplantation, Homologous/*adverse effects
Female ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Male ; Transplantation Conditioning/mortality ; Transplantation, Homologous/mortality
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Single-Nucleotide Polymorphisms Within the Thrombomodulin Gene (THBD) Predict Mortality in Patients With Graft-Versus-Host Disease.
Autorzy :: Rachakonda SP; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Penack O; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Dietrich S; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Blau O; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Blau IW; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Radujkovic A; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Isermann B; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Ho AD; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Uharek L; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Dreger P; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Kumar R; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Luft T; Sivaramakrishna P. Rachakonda and Rajiv Kumar, German Cancer Research Centre; Sascha Dietrich, Aleksandar Radujkovic, Anthony D. Ho, Peter Dreger, and Thomas Luft, University of Heidelberg, Heidelberg; Olaf Penack, Olga Blau, Igor Wolfgang Blau, and Lutz Uharek, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; and Berend Isermann, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. .; Pokaż więcej
Źródło :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Oct 20; Vol. 32 (30), pp. 3421-7. Date of Electronic Publication: 2014 Sep 15.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Polymorphism, Single Nucleotide*
Graft vs Host Disease/*genetics
Thrombomodulin/*genetics
Adolescent ; Adult ; Aged ; Angiopoietin-2/blood ; Female ; Genetic Linkage ; Genotype ; Graft vs Host Disease/mortality ; Humans ; Male ; Middle Aged ; Nitrates/blood ; Thrombomodulin/blood
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam.
Autorzy :: Penack O
Schwartz S
Thiel E
Wolfgang Blau I; Pokaż więcej
Źródło :: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2004 Nov 01; Vol. 39 (9), pp. 1401-2; author reply 1402-3.
Typ publikacji :: Letter; Comment
MeSH Terms :: False Positive Reactions*
Aspergillus/*immunology
Aspergillus/*isolation & purification
Mannans/*analysis
Adult ; Aged ; Humans ; Mannans/immunology ; Middle Aged ; Penicillanic Acid/analogs & derivatives ; Penicillanic Acid/therapeutic use ; Piperacillin/therapeutic use ; Piperacillin, Tazobactam Drug Combination ; Reagent Kits, Diagnostic
: Opinia redakcyjna

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Wolfgang Blau"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język